Search

everythinglearnresearchcommunity

for

Search:↓

Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Spironolactone improved hair density and quality in women with hair loss.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

The medicine Diane is effective in treating hair loss, severe acne, and excessive hair growth.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Understanding hormones is key to treating certain skin conditions.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.